Skip to main content

Table 4 Neonatal outcomes in different phenotypes of PCOS patients

From: Impact of dehydroepiandrosterone sulfate and free androgen index on pregnancy and neonatal outcomes in PCOS patients

 

FAI < 6.4

(n = 679)

FAI > 6.4

(n = 204)

P

DHEAS < 9.5 umol/l

(n = 552)

DHEAS > 9.5 umol/l

(n = 220)

P

Fetal sex

  

0.883

  

0.906

Male%

49.65(143/288)

51.52(34/66)

 

49.16(117/238)

47.22(34/72)

 

Female%

50.35(145/288)

48.48(32/66)

 

50.84(121/238)

52.78(38/72)

 

Birth Weight(g)

2962.45

2931.45

0.305

2960.13

2960.73

0.419

Birth Length(cm)

48.48

48.26

0.908

48.35

48.33

0.350

Macrosomia rate

1.74(5/288)

4.55(3/66)

0.167

2.52(6/238)

2.78(2/72)

1.000

Congenital malformations

3.12(9/288)

0

0.374

2.94(7/238)

1.39(1/72)

0.686

Caesarean section delivery

65.86(191/288)

70.15(47/66)

0.566.

70.29(168/238)

60.27(44/72)

0.117

Pregnancy Complications

21.06(60/288)

21.42(3/14)

0.709

28.94(69/238)

37.50(27/72)

1.000

  1. PCOS: polycystic ovary syndrome; FAI: free androgen index; DHEAS: dehydroepiandrosterone sulfate. p < 0.05 is considered to have significant statistical significance